Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05096182 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 3 words
    • Study title shortened, about 4 words
  2. Primary completion date: Dec 2022 to Mar 2027v2 Show 4 more changesShow less
    • Start date changed from estimate of Nov 2021 to Mar 10, 2022
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Apr 2027 to Mar 2027
    • Site contact updated
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This long-term follow-up study is a 5-year long-term follow-up study to evaluate long-term safety in Cellgram-CKD subjects. (refer to ClinicalTrials.gov. Identifier: NCT05042206).
Trial Details
NCT Number NCT05096182
Lead Sponsor Pharmicell Co., Ltd.
Conditions
(from sponsor)		 Chronic Kidney Disease
Related terms Renal Insufficiency, Chronic
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov